Biologics Manufacturing Market Report 2026
Download Free Sample Buy Now
Biologics Manufacturing Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Biologics Manufacturing Market Report 2026

Global Outlook – By Mode of Manufacturing (Contract Manufacturing, In-House Manufacturing), By Modality (Monoclonal Antibodies (mAbs), Biosimilar And Recombinant Proteins, Vaccines (recombinant/mRNA/Viral), Cell And Gene Therapies, Ribonucleic Acid-Based Therapeutics), By Disease Indication (Oncology, Autoimmune Disorders, Infectious Diseases, Neurological Disorders, Other Disease Indications) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Biologics Manufacturing Market Overview

• Biologics Manufacturing market size has reached to $42.04 billion in 2025

• Expected to grow to $106.08 billion in 2030 at a compound annual growth rate (CAGR) of 20.3%

• Growth Driver: Rising Prevalence Of Chronic Diseases Fueling The Growth Of The Market Due To Increasing Demand For Targeted Therapies

• Market Trend: Advanced Biologics CDMO Platforms Enable Faster Development Timelines

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Biologics Manufacturing Market?

Biologics manufacturing is the complex process of producing medicines derived from living organisms or their components. It involves cultivating genetically engineered cells or microorganisms in bioreactors to generate therapeutic proteins or other biological products, followed by purification techniques like filtration and chromatography to ensure safety and quality. This process enables the development of safe, effective, and high-quality biologic drugs, supporting personalized medicine and improving patient outcomes.

The main modes of manufacturing in biologics manufacturing are contract manufacturing and in-house manufacturing. Contract manufacturing refers to a production approach in which a company outsources the manufacturing of its biologic products to a specialized third-party organization. The different modalities include monoclonal antibodies (mAbs), biosimilar and recombinant proteins, vaccines, cell and gene therapies, and ribonucleic acid-based therapeutics, and are indicated for oncology, autoimmune disorders, infectious diseases, neurological disorders, and other disease indications.

Biologics Manufacturing Market Global Report 2026 Market Report bar graph

What Is The Biologics Manufacturing Market Size and Share 2026?

The biologics manufacturing market size has grown exponentially in recent years. It will grow from $42.04 billion in 2025 to $50.69 billion in 2026 at a compound annual growth rate (CAGR) of 20.6%. The growth in the historic period can be attributed to expansion of recombinant protein therapeutics, early adoption of mammalian cell culture systems, growth in vaccine manufacturing capacity, increasing outsourcing of biologics production, advancements in purification technologies.

What Is The Biologics Manufacturing Market Growth Forecast?

The biologics manufacturing market size is expected to see exponential growth in the next few years. It will grow to $106.08 billion in 2030 at a compound annual growth rate (CAGR) of 20.3%. The growth in the forecast period can be attributed to increasing demand for personalized biologics, rising investments in flexible manufacturing platforms, expansion of biosimilar development, growing adoption of digital bioprocessing tools, focus on cost-efficient large-scale production. Major trends in the forecast period include increasing adoption of single-use bioprocessing systems, rising deployment of continuous biomanufacturing, growing demand for high-volume monoclonal antibody production, expansion of modular biologics facilities, enhanced integration of advanced process control.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Biologics Manufacturing Market Segmentation

1) By Mode of Manufacturing: Contract Manufacturing, In-House Manufacturing

2) By Modality: Monoclonal Antibodies (mAbs), Biosimilar And Recombinant Proteins, Vaccines (recombinant/mRNA/Viral), Cell And Gene Therapies, Ribonucleic Acid-Based Therapeutics

3) By Disease Indication: Oncology, Autoimmune Disorders, Infectious Diseases, Neurological Disorders, Other Disease Indications

Subsegments:

1) By Contract Manufacturing: Mammalian Cell-Based Production, Microbial Fermentation Production, Cell-Free Protein Synthesis, Hybrid Manufacturing Systems

2) By In-House Manufacturing: Mammalian Cell Culture Production, Microbial Expression Systems, Continuous Bioprocessing, Single-Use Technology Production

What Is The Driver Of The Biologics Manufacturing Market?

The rising prevalence of chronic diseases is expected to propel the growth of the biologics manufacturing market going forward. Chronic diseases are persistent health conditions that develop slowly and last for an extended period, often requiring continuous medical care. The growing prevalence of chronic diseases is partly due to inactive lifestyles, as prolonged sitting and minimal physical activity raise the risk of diseases such as heart conditions and diabetes. Biologics manufacturing enhances chronic disease management by producing targeted therapies, making them effective for conditions such as diabetes, cancer, and autoimmune disorders. It reduces disease burden by providing consistent, high-quality biologic medicines, improving patient outcomes and treatment efficiency. For instance, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels, not high enough to be classified as diabetes) in 2023, marking an 18% increase from 3,065,825 cases in 2022. Therefore, the rising prevalence of chronic diseases is driving the growth of the biologics manufacturing industry.

Key Players In The Global Biologics Manufacturing Market

Major companies operating in the biologics manufacturing market are Johnson & Johnson, F. Hoffmann La-Roche Ltd., Pfizer Inc, AbbVie Inc., Eli Lilly and Company, Novartis AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., LG Life Sciences Ltd., Novo Nordisk A/S, Amgen Inc., FUJIFILM Holdings Corporation, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Lonza Group Ltd., Intas Pharmaceuticals Ltd., Samsung Biologics Co. Ltd., Fareva SA, Celltrion Inc., Evotec SE

Global Biologics Manufacturing Market Trends and Insights

Major companies operating in the biologics manufacturing market are focusing on developing advanced solutions, such as integrated biologics contract development and manufacturing organization platforms, to enhance end-to-end biologics development, production efficiency, and supply chain integration across multiple therapeutic modalities. Integrated biologics contract development and manufacturing organization (CDMO) platform refers to a comprehensive framework that combines biologics development, production, and supply services within a single, unified system. For instance, in June 2023, Catalent Inc., a US-based contract development and manufacturing company, expanded its OneBio Suite for integrated development, manufacturing, and supply across biologic modalities. The enhanced OneBio Suite offers a fully integrated biologics Contract Development and Manufacturing Organization (CDMO) platform that supports antibodies, cell and gene therapies, and mRNA-based products. It provides end-to-end services from development to fill-finish and packaging through a single contract and harmonized project management, enabling faster development timelines, improved scalability, and seamless global supply integration.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Biologics Manufacturing Market?

In September 2025, Terumo Corporation, a Japan-based medical technology company, acquired WuXi Biologics (Cayman) Inc. for an undisclosed amount. Through this acquisition, Terumo aims to expand its CDMO production capacity and global presence, enhancing its ability to provide integrated biologics manufacturing and fill-finish services for injectable therapies. WuXi Biologics (Cayman) Inc. is a China-based company offering end-to-end solutions for the discovery, development, and manufacturing of biologics.

Regional Insights

North America was the largest region in the biologics manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Biologics Manufacturing Market?

The biologics manufacturing market consists of sales of therapeutic proteins, enzymes, recombinant DNA products, blood factors, and other biologic-based therapeutics. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Biologics Manufacturing Market Report 2026?

The biologics manufacturing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the biologics manufacturing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Biologics Manufacturing Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $50.69 billion
Revenue Forecast In 2035 $106.08 billion
Growth Rate CAGR of 20.6% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Mode of Manufacturing, Modality, Disease Indication
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Johnson & Johnson, F. Hoffmann La-Roche Ltd., Pfizer Inc, AbbVie Inc., Eli Lilly and Company, Novartis AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., LG Life Sciences Ltd., Novo Nordisk A/S, Amgen Inc., FUJIFILM Holdings Corporation, Bo
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Biologics Manufacturing Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Biologics Manufacturing Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Biologics Manufacturing Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Biologics Manufacturing Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 5+Dg40:Dg46

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.5 Artificial Intelligence & Autonomous Intelligence

4.2. Major Trends

4.2.1 Increasing Adoption Of Single-Use Bioprocessing Systems

4.2.2 Rising Deployment Of Continuous Biomanufacturing

4.2.3 Growing Demand For High-Volume Monoclonal Antibody Production

4.2.4 Expansion Of Modular Biologics Facilities

4.2.5 Enhanced Integration Of Advanced Process Control

5. Biologics Manufacturing Market Analysis Of End Use Industries

5.1 Biopharmaceutical Companies

5.2 Contract Manufacturing Organizations

5.3 Vaccine Manufacturers

5.4 Biotechnology Firms

5.5 Research Institutes

6. Biologics Manufacturing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Biologics Manufacturing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Biologics Manufacturing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Biologics Manufacturing Market Size, Comparisons And Growth Rate Analysis

7.3. Global Biologics Manufacturing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Biologics Manufacturing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Biologics Manufacturing Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Biologics Manufacturing Market Segmentation

9.1. Global Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Contract Manufacturing, In-House Manufacturing

9.2. Global Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Monoclonal Antibodies (mAbs), Biosimilar And Recombinant Proteins, Vaccines (recombinant/mRNA/Viral), Cell And Gene Therapies, Ribonucleic Acid-Based Therapeutics

9.3. Global Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oncology, Autoimmune Disorders, Infectious Diseases, Neurological Disorders, Other Disease Indications

9.4. Global Biologics Manufacturing Market, Sub-Segmentation Of Contract Manufacturing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Mammalian Cell-Based Production, Microbial Fermentation Production, Cell-Free Protein Synthesis, Hybrid Manufacturing Systems

9.5. Global Biologics Manufacturing Market, Sub-Segmentation Of In-House Manufacturing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Mammalian Cell Culture Production, Microbial Expression Systems, Continuous Bioprocessing, Single-Use Technology Production

10. Biologics Manufacturing Market Regional And Country Analysis

10.1. Global Biologics Manufacturing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Biologics Manufacturing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Biologics Manufacturing Market

11.1. Asia-Pacific Biologics Manufacturing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Segmentation By Modality, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Biologics Manufacturing Market

12.1. China Biologics Manufacturing Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Segmentation By Modality, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Biologics Manufacturing Market

13.1. India Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Segmentation By Modality, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Biologics Manufacturing Market

14.1. Japan Biologics Manufacturing Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Segmentation By Modality, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Biologics Manufacturing Market

15.1. Australia Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Segmentation By Modality, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Biologics Manufacturing Market

16.1. Indonesia Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Segmentation By Modality, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Biologics Manufacturing Market

17.1. South Korea Biologics Manufacturing Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Segmentation By Modality, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Biologics Manufacturing Market

18.1. Taiwan Biologics Manufacturing Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Segmentation By Modality, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Biologics Manufacturing Market

19.1. South East Asia Biologics Manufacturing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Segmentation By Modality, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Biologics Manufacturing Market

20.1. Western Europe Biologics Manufacturing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Segmentation By Modality, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Biologics Manufacturing Market

21.1. UK Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Segmentation By Modality, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Biologics Manufacturing Market

22.1. Germany Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Segmentation By Modality, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Biologics Manufacturing Market

23.1. France Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Segmentation By Modality, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Biologics Manufacturing Market

24.1. Italy Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Segmentation By Modality, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Biologics Manufacturing Market

25.1. Spain Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Segmentation By Modality, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Biologics Manufacturing Market

26.1. Eastern Europe Biologics Manufacturing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Segmentation By Modality, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Biologics Manufacturing Market

27.1. Russia Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Segmentation By Modality, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Biologics Manufacturing Market

28.1. North America Biologics Manufacturing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Segmentation By Modality, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Biologics Manufacturing Market

29.1. USA Biologics Manufacturing Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Segmentation By Modality, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Biologics Manufacturing Market

30.1. Canada Biologics Manufacturing Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Segmentation By Modality, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Biologics Manufacturing Market

31.1. South America Biologics Manufacturing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Segmentation By Modality, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Biologics Manufacturing Market

32.1. Brazil Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Segmentation By Modality, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Biologics Manufacturing Market

33.1. Middle East Biologics Manufacturing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Segmentation By Modality, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Biologics Manufacturing Market

34.1. Africa Biologics Manufacturing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Segmentation By Modality, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Biologics Manufacturing Market Regulatory and Investment Landscape

36. Biologics Manufacturing Market Competitive Landscape And Company Profiles

36.1. Biologics Manufacturing Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Biologics Manufacturing Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Biologics Manufacturing Market Company Profiles

36.3.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

36.3.2. F. Hoffmann La-Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

37. Biologics Manufacturing Market Other Major And Innovative Companies

Novartis AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., LG Life Sciences Ltd., Novo Nordisk A/S, Amgen Inc., FUJIFILM Holdings Corporation, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Lonza Group Ltd., Intas Pharmaceuticals Ltd., Samsung Biologics Co. Ltd., Fareva SA, Celltrion Inc., Evotec SE

38. Global Biologics Manufacturing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Biologics Manufacturing Market

40. Biologics Manufacturing Market High Potential Countries, Segments and Strategies

40.1 Biologics Manufacturing Market In 2030 - Countries Offering Most New Opportunities

40.2 Biologics Manufacturing Market In 2030 - Segments Offering Most New Opportunities

40.3 Biologics Manufacturing Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Biologics Manufacturing Market, Overview Of Key Products - Product Examples
  • Table 2: Global Biologics Manufacturing Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Biologics Manufacturing Market, Supply Chain Analysis
  • Table 4: Global Biologics Manufacturing Market, Major Raw Material Providers
  • Table 5: Global Biologics Manufacturing Market, Major Resource Providers
  • Table 6: Global Biologics Manufacturing Market, Major Manufacturers (Suppliers)
  • Table 7: Global Biologics Manufacturing Market, Major Distributors And Channel Partners
  • Table 8: Global Biologics Manufacturing Market, Key Technologies & Future Trends
  • Table 9: Global Biologics Manufacturing Market, Major Trends
  • Table 10: Global Biologics Manufacturing Market, Major End Users
  • Table 11: Global Biologics Manufacturing Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Biologics Manufacturing Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Biologics Manufacturing Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Biologics Manufacturing Market - TAM, US$ Billion, 2025
  • Table 15: Global Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Biologics Manufacturing Market, Sub-Segmentation Of Contract Manufacturing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Biologics Manufacturing Market, Sub-Segmentation Of In-House Manufacturing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Biologics Manufacturing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Biologics Manufacturing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Indonesia, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: South Korea, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Taiwan, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South East Asia, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Western Europe, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: UK, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Germany, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: France, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Italy, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Spain, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Eastern Europe, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Russia, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: North America, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: USA, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: Canada, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: South America, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Brazil, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Middle East, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Africa, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Global Biologics Manufacturing Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 95: Global Biologics Manufacturing Market - Company Scoring Matrix
  • Table 96: Johnson & Johnson Financial Performance
  • Table 97: F. Hoffmann La-Roche Ltd. Financial Performance
  • Table 98: Pfizer Inc Financial Performance
  • Table 99: AbbVie Inc. Financial Performance
  • Table 100: Eli Lilly and Company Financial Performance
  • Table 101: Global Biologics Manufacturing Market, Competitive Benchmarking (In USD Billions)
  • Table 102: Global Biologics Manufacturing Market, Competitive Dashboard
  • Table 103: Global Biologics Manufacturing Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 104: Global, Biologics Manufacturing Market Size Gain ($ Billion), Segmentation By Mode of Manufacturing, 2025 – 2030
  • Table 105: Global, Biologics Manufacturing Market Size Gain ($ Billion), Segmentation By Modality, 2025 – 2030
  • Table 106: Global, Biologics Manufacturing Market Size Gain ($ Billion), Segmentation By Disease Indication, 2025 – 2030

List Of Figures

    Figure 1: Global Biologics Manufacturing Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Biologics Manufacturing Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Biologics Manufacturing Market, Supply Chain Analysis
  • Figure 4: Global Biologics Manufacturing Market, Major Raw Material Providers
  • Figure 5: Global Biologics Manufacturing Market, Major Resource Providers
  • Figure 6: Global Biologics Manufacturing Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Biologics Manufacturing Market, Major Distributors And Channel Partners
  • Figure 8: Global Biologics Manufacturing Market, Key Technologies & Future Trends
  • Figure 9: Global Biologics Manufacturing Market, Major Trends
  • Figure 10: Global Biologics Manufacturing Market, Major End Users
  • Figure 11: Global Biologics Manufacturing Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Biologics Manufacturing Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Biologics Manufacturing Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Biologics Manufacturing Market - TAM, US$ Billion, 2025
  • Figure 15: Global Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Biologics Manufacturing Market, Sub-Segmentation Of Contract Manufacturing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Biologics Manufacturing Market, Sub-Segmentation Of In-House Manufacturing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Biologics Manufacturing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Biologics Manufacturing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Indonesia, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: South Korea, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Taiwan, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South East Asia, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Western Europe, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: UK, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Germany, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: France, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Italy, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Spain, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Eastern Europe, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Russia, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: North America, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: USA, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: Canada, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: South America, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Brazil, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Middle East, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Africa, Biologics Manufacturing Market, Segmentation By Mode of Manufacturing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Biologics Manufacturing Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Biologics Manufacturing Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Global Biologics Manufacturing Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 95: Global Biologics Manufacturing Market - Company Scoring Matrix
  • Figure 96: Johnson & Johnson Financial Performance
  • Figure 97: F. Hoffmann La-Roche Ltd. Financial Performance
  • Figure 98: Pfizer Inc Financial Performance
  • Figure 99: AbbVie Inc. Financial Performance
  • Figure 100: Eli Lilly and Company Financial Performance
  • Figure 101: Global Biologics Manufacturing Market, Competitive Benchmarking (In USD Billions)
  • Figure 102: Global Biologics Manufacturing Market, Competitive Dashboard
  • Figure 103: Global Biologics Manufacturing Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 104: Global, Biologics Manufacturing Market Size Gain ($ Billion), Segmentation By Mode of Manufacturing, 2025 – 2030
  • Figure 105: Global, Biologics Manufacturing Market Size Gain ($ Billion), Segmentation By Modality, 2025 – 2030
  • Figure 106: Global, Biologics Manufacturing Market Size Gain ($ Billion), Segmentation By Disease Indication, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Biologics Contract Development Market Report 2026 - Global Outlook – By Source (Microbial, Mammalian, Other Sources), By Indication (Oncology, Immunological Disorders, Cardiovascular Disorders, Hematological Disorders, O...

Biologics Outsourcing Market Report 2026 - Global Outlook – By Product Type (Antibodies, Recombinant, Vaccines, Protein, Other Products), By Source (Human, Microbial, Other Sources), By Application (Oncology, Cellular An...

Biologics Testing Market Report 2026 - Global Outlook – By Product (Reagents And Kits, Instruments, Other Products), By Test Type (Endotoxin Test, Sterility Test, Mycoplasma Tests, Bioburden Tests, Residual Host-Cell Pro...

Agricultural Biologics Market Report 2026 - Global Outlook – By Type (Biopesticides, Biofertilizers, Biostimulants), By Source (Microbials, Macrobials, Biochemicals, Other Sources), By Mode of Application (Foliar Spray, ...

Biopharmaceuticals Contract Manufacturing Market Report 2026 - Global Outlook – By Product (Biologics, Monoclonal Antibodies (MABs), Recombinant Proteins, Vaccines, Antisense, RNAI, And Molecular Therapy, Biosimilars), B...

Veterinary Biologics Market Report 2026 - Global Outlook – By Product (Vaccines, Diagnostic Kits, Immunomodulators, Antiserums And Antibodies, Other Products), By Disease Type (Bluetongue, Foot And Mouth Disease, Brucell...

Digital Biomanufacturing Market Report 2026 - Global Outlook – By Type (Manufacturing Technologies, Analytical And Process Control Technologies, Software, Other Types), By Types Of Biologic(s) Manufactured (Antibodies, C...

Biologics CDMO Market Report 2026 - Global Outlook – By Cell Type (Mammalian, Non-Mammalian), By Product Type (Biologics, Biosimilars), By Service Type (Drug Substance Manufacturing, Drug Product (Fill–Finish) Manufactur...

Frequently Asked Questions

The Biologics Manufacturing market was valued at $42.04 billion in 2025, increased to $50.69 billion in 2026, and is projected to reach $106.08 billion by 2030.

The global Biologics Manufacturing market is expected to grow at a CAGR of 20.3% from 2026 to 2035 to reach $106.08 billion by 2035.

Some Key Players in the Biologics Manufacturing market Include, Johnson & Johnson, F. Hoffmann La-Roche Ltd., Pfizer Inc, AbbVie Inc., Eli Lilly and Company, Novartis AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., LG Life Sciences Ltd., Novo Nordisk A/S, Amgen Inc., FUJIFILM Holdings Corporation, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Lonza Group Ltd., Intas Pharmaceuticals Ltd., Samsung Biologics Co. Ltd., Fareva SA, Celltrion Inc., Evotec SE .

Major trend in this market includes: Advanced Biologics CDMO Platforms Enable Faster Development Timelines. For further insights on this market. request a sample here

North America was the largest region in the biologics manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biologics manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us